Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Whitmore

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Allergy and Clinical Immunology|June 9, 2001
Efficacy of soluble IL-4 receptor for the treatment of adults with asthmaL C Borish, H S Nelson, J Corren, et al.
AIDS (London, England)|April 19, 2000
Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. Leukine/HIV Study GroupJ B Angel, K High, F Rhame, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Randomized, placebo-controlled, multicenter trial of granulocyte-macrophage colony-stimulating factor as infection prophylaxis in oncologic surgery. Leukine Surgical Prophylaxis Research GroupN J Meropol, D E Wood, J Nemunaitis, et al.
The Journal of Urology|July 27, 2011
Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancerSimon J Hall, Laurence Klotz, Allan J Pantuck, et al.
The Journal of Rheumatology|July 2, 2004
Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanerceptPhillip J Mease, Christopher T Ritchlin, Richard W Martin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 17, 1998
Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trialsJ B Whitmore, M G Kris, P J Hesketh, et al.
International Immunopharmacology|November 17, 2001
Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylationS M Vogen, N J Paczkowski, L Kirnarsky, et al.
The Journal of Rheumatology|March 17, 2006
Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experienceLarry W Moreland, Michael E Weinblatt, Edward C Keystone, et al.
Urology|July 31, 2013
Quality of life after sipuleucel-T therapy: results from a randomized, double-blind study in patients with androgen-dependent prostate cancerTomasz M Beer, Paul F Schellhammer, John M Corman, et al.
The Journal of Rheumatology|July 5, 2005
Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritisMark C Genovese, Joan M Bathon, Roy M Fleischmann, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology|June 9, 2001
Efficacy of soluble IL-4 receptor for the treatment of adults with asthmaL C Borish, H S Nelson, J Corren, et al.
AIDS (London, England)|April 19, 2000
Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. Leukine/HIV Study GroupJ B Angel, K High, F Rhame, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Randomized, placebo-controlled, multicenter trial of granulocyte-macrophage colony-stimulating factor as infection prophylaxis in oncologic surgery. Leukine Surgical Prophylaxis Research GroupN J Meropol, D E Wood, J Nemunaitis, et al.
The Journal of Urology|July 27, 2011
Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancerSimon J Hall, Laurence Klotz, Allan J Pantuck, et al.
The Journal of Rheumatology|July 2, 2004
Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanerceptPhillip J Mease, Christopher T Ritchlin, Richard W Martin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 17, 1998
Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trialsJ B Whitmore, M G Kris, P J Hesketh, et al.
International Immunopharmacology|November 17, 2001
Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylationS M Vogen, N J Paczkowski, L Kirnarsky, et al.
The Journal of Rheumatology|March 17, 2006
Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experienceLarry W Moreland, Michael E Weinblatt, Edward C Keystone, et al.
Urology|July 31, 2013
Quality of life after sipuleucel-T therapy: results from a randomized, double-blind study in patients with androgen-dependent prostate cancerTomasz M Beer, Paul F Schellhammer, John M Corman, et al.
The Journal of Rheumatology|July 5, 2005
Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritisMark C Genovese, Joan M Bathon, Roy M Fleischmann, et al.
Pageof 6